TNFRSF8 and primary effusion lymphoma: PEL is a terminally differentiated LBCL and, therefore, similarly to PBL, is positive for plasma cell-associated markers, EMA and CD30, and negative for mature B-cell markers, although B-cell markers may more often be found in the solid/EC variant of PEL.